Neopterin and a soluble interleukin-2 receptor in patients with systemic lupus erythematodes;Neopterin a solubilní receptor interleukinu-2 u nemocných se systérnovým lupus erythematodes

Vnitrni Lekarstvi

Volumn 50, Issue 6, 2004, Pages 422-427

  Horák, Pavel ^a   Hermanova Z ^a   Ordeltova M ^a   Faltynek L ^a   Kusa L ^a   Budikova M ^a   Vavrdova V ^a   Opichalova D ^a   Ciferska H ^a   Scudla V ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Disease activity; ECLAM index; Serum neopterin; Soluble interleukin 2 receptor (sIL 2r); Systemic lupus erythematodes (SLE)

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DNA ANTIBODY; FAS LIGAND; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; NEOPTERIN; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CORRELATION FUNCTION; DISEASE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HUMANS; INTERLEUKIN-2; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NEOPTERIN; PROGNOSIS;

EID: 3042629579     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Alcocer-Varela, J., Alarcon-Segovia, D.: Longitudinal study on the production of and cellular response to interleukin-2 in patients with systemic lupus erythematosus. Rheumatol. Int. 1995; 15: 57-63
2. Bencivelli, W. and European Consensus Study Group for Disease Activity in SLE: Disease activity in SLE: Report of the consensus study group of the European workshop for rheumatology research. III. Development of the computerized clinical chart and its application to the comparison of different indices of disease activity. Clin. Exp. Rheumatol. 1992; 10: 549-554
3. Birk, D., Gansauge, F., Gansauge, S. et al.: Levels of serum neopterin are increased in pancreatic cancer patients and correlate with the prognosis. Eur. J. Med. Res. 1999; 4: 156-160
4. Carlson, I. H.: New markers in serum for lymphocyte activation for predicting allograph rejection. Neopterin and soluble interleukin-2 receptor. Clin. Lab. Med. 1992; 12: 99-111
5. Crispin, J. C., Alcocer-Varela, J.: Interleukin-2 and systemic lupus erythematosus-fifteen years later. Lupus 1998; 7: 214-222
6. Gurfinkel, E. P., Scirica, B. M., Bozovich, G. et al.: Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Am. J. Cardiol. 1999; 83: 515-518
7. Hannonen, P., Tikanoja, S., Hakola, M. et al.: Urinary neopterin index as measure of rheumatoid activity. Scand. J. Rheumatol. 1986; 15: 148-152
8. Horák, P., Heřmanová, Z., Pospíšil, Z. et al.: Sérový neopterin a solubilní receptor interleukinu-2 jakq ukazatelé aktivity systémového lupus erythematodes. Cs. Revmatol., 1996; 4: 161-165
9. Huber, C., Batchelor, J. R., Fuchs, D. et al.: Immune response associated production of neopterin release from macrophages primarily under control of interferon gamma. J. Exp. Med. 1984; 160: 310-316
10. Immanuel, C., Swamy, R., Kannapiran, M. et al.: Neopterin as a marker for cell-mediated immunity in patients with pulmonary tuberculosis. Int. J. Tuberc. Lung. Dis. 1997; 1: 175-180
11. Itoh, M., Goto, Y., Ohta, Y. et al.: Relations between surface expression of the interleukin-2 receptor and release of the soluble form of the receptor in cultured mononuclear cells from patients with rheumatoid arthritis or systemic lupus erythematosus. Clin. Rheumatol. 1998; 17: 26-30
12. Josimovic-Alasevic, O., Feldmeier, H., Zwingenberger, K. et al.: Interleukin-2 receptor in patients with localized and systemic parasitic diseases. Clin. Exp. Immunol. 1988; 72: 249-254
13. Konečný, M., Ehrmann, J., Bártek, J. et al.: The level of neopterin in blood serum as one of the possible prognostic markers of Cohn's disease activity. Acta Univ. Palacki Olomouc Fac. Med. 1996; 140: 47-48
14. Laut, J., Seenitzer, D., Petrucci, R. et al.: Soluble interleukin-2 receptor levels in lupus nephritis. Clin. Nephrol. 1992; 38, 179-184
15. Lim, K. L., Muir, K., Powell, R. J.: Urine neopterin: A new parameter for serial monitoring of disease activity in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 1994; 53: 743-748
16. Lissoni, P., Brivio, F., Viviani, S. et al.: Which immunological parameters are clinically essential to monitor IL-2 cancer immunotherapy? J. Biolog. Regul. Homeost. Agents 1999; 13: 110-114
17. Martinez-Bru, C., Cortes, M., Planella, T. et al.: Beta 2-microglobulin and immunoglobulins are more useful markers of disease progression in HIV than neopterin and adenosine deaminase. Ann. Clin. Biochem. 1999; 36: 601-608
18. Minami, Y., Kono, T., Miyazaki, T. et al.: The IL-2 receptor complex: It's structure, function, and target genes. Ann. Rev. Immunol. 1993; 11: 245-267
19. Nassonov, E. L., Samsonov, M. Y., Tilz, G. P. et al.: Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor in Wegeners granulomatosis. J. Rheumatol. 1997; 24: 666-670
20. Sadeghi, M., Daniel, V., Weimer, R. et al.: Differential early posttransplant cytokine responses in living and cadaver donor renal allografts. Transplantation 2003; 75: 1351-1355
21. Samsonov, M. Y., Tilz, G. P., Egorova, O. et al.: Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus 1995; 4: 29-32
22. Schubert, C., Lampe, A., Rumpold, G. et al.: Daily psychosocial stressors interfere with the dynamics of urine neopterin in a patient with systemic lupus erythematosus: an integrative single-case study. Psychosom. Med. 1999; 61: 876-882
23. Spronk, P. E., Terborg, E. J., Huitema, M. G. et al.: Changes in levels of soluble T-cell activation markers, sIL-2r, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study. Ann. Rheum. Dis. 1994; 53: 235-239
24. Tan, E. M., Cohen, A. S., Fries, J. F. et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 1271-1277
25. Wachter, H., Fuchs, D., Hausen, A. et al.: Neopterin as marker for activation of cellular immunity: Immunological basis and clinical application. Adv. Clin Chem. 1989; 27: 81-141
26. Yokoyama, K., Tajima, M., Yoshida, H. et al.: Plasma pteridine concentrations in patients with chronic renal failure. Nephrol. Dial. Trans. 2002; 17: 1032-1036
27. Ziegenhagen, M. W., Benner, U. K., Zissel, G. et al.: Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2r are prognostic markers. Am. J. Respir. Crit. Care Med. 1997; 156: 1586-1592